Virologic outcome at Week 48 and specific TDR at Baseline known to affect NRTI Backbone.
- Max Lataillade (183356)
- Jennifer Chiarella (183360)
- Rong Yang (107028)
- Steven Schnittman (364353)
- Victoria Wirtz (364354)
- Jonathan Uy (143781)
- Daniel Seekins (183368)
- Mark Krystal (364355)
- Marco Mancini (364356)
- Donnie McGrath (364357)
- Birgitte Simen (183369)
- Michael Egholm (180599)
- Michael Kozal (183380)
Publication date
February 2013
DOIAbstract
<p>Thymidine Analog Mutations (TAMs); Virologic Success at week 48 (VS), Virologic Failure at week 48 (VF). Transmitted Drug Resistance Mutations (TDRs); 9 subjects with M184V/I +/− TAMs and/or +/− K65R at baseline. 16 subjects with >1 TAMs at baseline. 2 subjects with K65R at baseline.</p
Add to ORKG